Avid Bioservices Inc (CDMO): Multiplikator forward rega marang pendapatan

Avid Bioservices, Inc. (CDMO) focuses on the long-term expansion of production capacities to increase margins within the B2B sector. Synergy with biotech laboratories through strategic alliances accelerates the launch of new drugs. Logistics optimization and IT outsourcing allow the company to concentrate on the production of biologics. The forward P/S ratio helps identify asset overheating, with the value currently maintained at 5.30.

avidbio.com - Rasio kapitalisasi marang dodolan sing dikarepake CDMO (periode 04.07.2022 - 16.02.2025)

Rincian metrik komprehensif lan analitis Avid Bioservices, Inc. (CDMO)

- rega saiki lan proyeksi nilai saham:

Rega saham Avid Bioservices Inc.|CDMO - Prakiraan konsensus analis

- data kapitalisasi bursa:

Biji pasar Avid Bioservices, Inc.|CDMO - Nilai Total Perusahaan

- rincian valuasi buku bisnis:

Nilai Buku saben Saham Avid Bioservices|CDMO - Pambiji Buku Bisnis|Rasio Kapitalisasi Pasar marang Nilai Buku avidbio.com|CDMO - Total Aset Bisnis

- rincian struktur utang lan likuiditas bisnis:

Rasio Total Utang marang Ekuitas Avid Bioservices, Inc.|CDMO - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang modal Avid Bioservices|CDMO - Utang perusahaan|Utang-utang marang kapitalisasi buku Avid Bioservices, Inc|CDMO - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan Avid Bioservices|Likuiditas cepet avidbio.com

- rincian asil keuangan lan kelipatan valuasi:

CDMO - Asil keuangan resik|Proyeksi bathi mangsa ngarep Avid Bioservices, Inc.|CDMO - Kapitalisasi marang bathi|Rega marang bathi mangsa ngarep Avid Bioservices, Inc.|CDMO - Koefisien bali modal nimbang wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Avid Bioservices, Inc.|CDMO - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Avid Bioservices|CDMO - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi EPS kuartalan avidbio.com|CDMO - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Avid Bioservices, Inc.

- indikator volume dodolan lan pendapatan:

CDMO - Total pendapatan perusahaan|Prakiraan pendapatan perusahaan Avid Bioservices Inc|CDMO - Koefisien rega marang pendapatan|Multiplikator forward rega marang pendapatan Avid Bioservices Inc.

Ringkesan analitik perusahaan:Avid Bioservices Inc CDMO

Produk sing diprodhuksi Avid Bioservices Inc

This metric measures the market value of an asset relative to expected sales volume, allowing for an assessment of demand stability for shares regardless of trading volumes. By analyzing the forward P/S indicator, an investor determines the valuation volatility of Avid Bioservices, Inc. (CDMO), where a stable ratio confirms the value of capital barriers in the form of FDA-certified bioreactors and a high regulatory barrier to entry.

Analisis perusahaan pesaing

Rasio rega marang prakiraan pendapatan IQVIA Holdings IQV|Laboratory Corporation of America - Rasio rega marang prakiraan pendapatan|Medpace Holdings - Multiplikator Forward P/S|ICON (ICLR) - Multiplikator forward rega marang pendapatan|Charles River (CRL) - Rasio rega marang prakiraan pendapatan|EVO: Rasio rega marang pendapatan sing dikarepake|Multiplikator forward rega marang pendapatan FTRE|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Lifecore Biomedical LFCR|Multiplikator Forward P/S OABI|Rasio kapitalisasi marang dodolan sing dikarepake Inotiv|Multiplikator Forward P/S CTLT (Catalent, Inc)|Rasio kapitalisasi marang dodolan sing dikarepake NightHawk Biosciences (SCPX)